Other Hematopoietic | Pediatrics | Sickle Cell Disorders, Phase I

A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime

Volunteers
Health Professionals

What is the purpose of this trial?

The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient for engraftment of donor hematopoietic cells. It is also to determine major toxicities from these conditioning regimens, within the first 100 days after transplantation.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Lakshmanan Krishnamurti

lakshmanan.krishnamurti@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Lakshmanan Krishnamurti, MD
Professor of Pediatrics (Hematology/Oncology); Chief, Pediatric Hematology and Oncology

Sub-Investigators

Last Updated
11/07/2024
Study HIC
#2000021396